bw-755c has been researched along with Coronary Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moncada, S; Mullane, KM | 1 |
| Bednar, M; Mullane, KM; Pinto, A; Smith, B | 1 |
| Cooper, DR; Kelliher, GJ; Kowey, PR | 1 |
3 other study(ies) available for bw-755c and Coronary Disease
| Article | Year |
|---|---|
The salvage of ischaemic myocardium by BW755C in anaesthetised dogs.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Anti-Inflammatory Agents; Coronary Disease; Disease Models, Animal; Dogs; Indomethacin; Male; Myocardial Infarction; Pyrazoles; Risk | 1982 |
Nafazatrom-induced salvage of ischemic myocardium in anesthetized dogs is mediated through inhibition of neutrophil function.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; Cell Aggregation; Coronary Disease; Dogs; Fibrinolytic Agents; Glucuronidase; Male; Myocardial Infarction; Myocardium; Neutrophils; Platelet Aggregation; Pyrazoles; Pyrazolones; Superoxides | 1985 |
Modulation of arachidonic acid metabolites and vulnerability to ventricular fibrillation during myocardial ischemia in the cat.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Arachidonic Acids; Cardiac Pacing, Artificial; Cats; Chromones; Coronary Disease; Female; Male; Naphthoquinones; ortho-Aminobenzoates; Pyrazoles; SRS-A; Sulfinpyrazone; Ventricular Fibrillation | 1988 |